ライフサイエンスコーパス: IP

1 IP correlates with self-reported risk behavior among MSM

2 IP is associated with significantly lower perceived pain

3 IP of thymol included and encapsulated WO-TAGs were foun

4 IP RIT (131)I-omburtamab was well tolerated with minimal

5 IP surgery was associated with significantly less pain c

6 IP(3) receptor, gap junction, and mechanosensitive calci

7 IP(3)R (Inositol-trisphosphate receptor) stimulation pro

8 IP(6) interacts with the receptor-binding surface of arr

9 IPs (Dll1+) extensively targeted contacts to mitotic NSC

10 IPs synthesis is believed to originate with IP(3) genera

11 ed patients (n=933) and INTERMACS profile 1 (IP-1) patients not supported by ECMO (n=2362).

12 armacoinvasive approach (16.3% versus 23.1%, IP-weighted hazard ratio, 0.84; 95% CI, 0.72-0.99; P=0.0

13 t with Vip1 evolving to modulate levels of 1-IP(7) and 1,5-IP(8) Individual perturbations in kinase a

14 nterferon (IFN)-gamma- inducible protein 10 (IP-10), monocyte chemoattractant protein-1 (MCP-1), IFN-

15 factor, interferon gamma-induced protein 10 (IP-10), soluble interleukin-6 receptor (sIL-6R), sCD14,

16 izing a novel interferon-induced protein 10 (IP-10)-adjuvanted HIV-1 DNA prime followed by a monophos

17 mmatory interferon gamma-induced protein 10 (IP-10/CXCL10) in HIV regardless of cognition, but elevat

18 gher production of IL-17A, IFN-gamma, IL-10, IP-10, GM-CSF, sFasL, Granzyme A, Granzyme B, Granulysin

19 ng; IL-6, IL-10, MCP-1, sVCAM-1, MIP-1alpha, IP-10, GM-CSF, M-CSF, TNF-alpha, IFN-gamma, VCAM-1, ICAM

20 This resulted in 314 reports involving 204 IPs.

21 s (26% EXT), surgical implant placement (25% IP), mucogingival surgeries (21% MGS), and pocket elimin

22 port structural findings of the human type-3 IP(3)R (IP(3)R-3) obtained by cryo-EM (at an overall res

23 g of PLCbeta, inositol triphosphate (IP(3)), IP(3) receptors, and Ryanodine receptors is required onl

24 We applied AIControl to 410 IP datasets in the ENCODE ChIP-seq database, using 440 c

25 olving to modulate levels of 1-IP(7) and 1,5-IP(8) Individual perturbations in kinase and pyrophospha

26 TREK-1 activation also decreased IL-6, IP-10, and CCL-2 secretion from primary AECs.

27 the lungs, most notably, IL-1RA, IL-6, IL-8, IP-10, and monocyte chemoattactant protein-1, consistent

28 However, how these mutations affect IP(3)R function, and how the perturbation of as-sociated

29 d pharmacokinetic (PK) profile in mice after IP dosing with compound exposure above the IC(50) for 6

30 with short-interfering RNA directed against IP(3)R1.

31 Our Ago2-IP-seq miRNA profile could be considered an important da

32 The proportion of all IPs recorded as unsupervised increased through training

33 whereas cytokine stress specifically alters IP(3)R activity.

34 ry mechanism must differ qualitatively among IP(3)R subtypes because of their diverse loop sequences,

35 renal concentration of l-fucose following an IP bolus given before the ischemia induction procedure -

36 chemical composition, but GCHL, SC, TiB, an IP presented the best decontamination outcomes.

37 o-inflammatory molecules including MCP-1 and IP-10.

38 protein levels and cell counts, and IL-6 and IP-10 concentrations.

39 ity and is associated with elevated IL-6 and IP-10 levels, two key players in the cytokine storm.

40 ctable levels of the IP(6)-derived IP(7) and IP(8) and also exhibit reduced synthesis of the IP(5)-de

41 ng Cx43 or Cx50 were loaded with Fluo-8, and IP(3) or Ca(2+) were delivered via patch pipette to one

42 ses in AF versus control cardiomyocytes, and IP(3)R-blockade suppressed the AF-related [Ca(2+)](Nuc)

43 latable metronomic low-dose chemotherapy and IP pharmacokinetics using biodegradable nanotextile impl

44 per 1 000 patient-days at risk during CP and IP, respectively.

45 did not significantly differ between CP and IP.

46 m/calmodulin-dependent protein kinase II and IP(3) pathways.

47 (cross talk) between ryanodine receptor and IP(3)R channels on the Ca(2+) transient and examine the

48 onclude that the major effect of the SOS and IP changes is to substantially increase trimer stability

49 Without the SOS and IP changes, proteolytically cleaved trimers tend to disi

50 esults were obtained with GCHL, SC, TiB, and IP, with no difference between these protocols (P >0.05)

51 across a broad range of parameter values and IP(3) concentrations.

52 The content of alpha-galactosides and IPs was determined by high performance liquid chromatogr

53 Water transport is activated and, IP(3) R, TRPA1, TRPV4, and Aquaporin-4 are all involved

54 into 2 groups regarding treatment approach: IP (test) and no IP (control).

55 antiviral immunity and inflammation such as IP-10, TNF, IL-6, and TNFRII.

56 Using calcium imaging techniques to assess IP(3)R channel function, we observed that all the mutati

57 Flies with attenuated IP(3)Rs in these presynaptic dopaminergic neurons exhibi

58 Because IP(6) is ubiquitously present in cells, this suggests ph

59 rough training (P < 0.05) and varied between IPs with 91.2% of appendicectomies (mp = 20), 40.6% of e

60 rial-cardiomyocyte nucleoplasmic [Ca(2+)] by IP(3)R1-upregulation involving miR-26a, leading to enhan

61 and this protective effect was abrogated by IP antagonists.

62 biological processes that are controlled by IP(3)Rs.

63 Each injection was followed by IP saline infusion.

64 diomyocytes; these changes were prevented by IP(3)R knockdown with short-interfering RNA directed aga

65 nctioning of the ER-localized Ca(2+) channel IP(3)R and the activity of the sarco-endoplasmic reticul

66 FRET-FLIM and co-IP demonstrated that the glutathione transferase GSTU4,

67 rs of MATalpha1 by coimmunoprecipitation (co-IP) and mass spectrometry.

68 pendent untargeted coimmunoprecipitation (co-IP) approaches with the biosynthetic enzymes CYP71B15 an

69 iption polymerase chain reaction), ELISA, co-IP, immunostaining, knockdown and overexpression studies

70 ere identified in co-immunoprecipitation (co-IP) experiments, albeit the minimal complex sufficient f

71 lly mutated RORalpha at Ser100 residue in co-IP assay.

72 cipitation followed by mass spectrometry (co-IP/MS) for proteins that differentially associated with

73 e interactions were confirmed by targeted co-IP and Forster resonance energy transfer measurements ba

74 Interacting proteins were confirmed using co-IP using recombinant proteins, liver lysates, and mitoch

75 f IP-10, IL-6, and both biomarkers combined (IP-10+IL-6) were 0.78, 0.88, and 0.96, respectively.

76 Additionally, we designed concatenated IP(3)R constructs to create tetrameric channels with a p

77 The levels of CTACK, IP-10, SCGF-beta, and SDF-1 alpha were significantly hig

78 -CSF, IL-10, CCL2/MCP-1, CCL3/MIP-1a, CXCL10/IP-10, CCL5/RANTES, and CCL20/MIP-3a.

79 Increased serum concentrations of CXCL10/IP-10 and GM-CSF, together with higher nasopharyngeal SA

80 ntial Organ Failure Assessment, serum CXCL10/IP-10 (P = 0.047) and GM-CSF (P = 0.050) were higher and

81 (MPLA+QS-21)-adjuvanted Env protein boost (D(IP-10) P(ALFQ)) in macaques, we observed higher anti-Env

82 The D(IP-10) P(ALFQ) regimen also increased vaginal and rectal

83 alum-adjuvanted Env protein (DP(ALFA)) The D(IP-10) P(ALFQ) vaccine regimen elicited higher anti-Env

84 ve nondetectable levels of the IP(6)-derived IP(7) and IP(8) and also exhibit reduced synthesis of th

85 of highly proliferative disease and distinct IP but does not appear to be an independent variable inf

86 ary immune-privileged site-associated DLBCL (IP-DLBCL) samples originating in the testis or central n

87 Last, we show that enhanced IP signaling in GPRC5B-deficient SMCs not only facilitat

88 ation involving miR-26a, leading to enhanced IP(3)R1-CaMKII-HDAC4 signaling and L-type calcium curren

89 are regulatory requirements for established IP programs, but they do not specify leadership structur

90 The type of procedure experienced (IP injection or anaesthesia), and the duration after whi

91 After extrusion, IPs content was significantly decreased and TIA as well

92 occurring within the NT during and following IP(3) binding that lead to channel gating.

93 t the SD - IBC interface seemed critical for IP(3)R activation.

94 Nine measurements for IP, 13 measurements for IA, 11 measurements for EP, and

95 (2+) duty cycle as a plausible mechanism for IP(3)-dependent hypertrophic signaling via Ca(2+)-sensit

96 codes and competency assessment outcomes for IPs were assessed by year of training.

97 Apart from IP protocol, all the other groups presented a more hydro

98 es reflecting inflammation (IL-6, IFN-gamma, IP-10, IL-1RA, IL-10), chemotaxis (IL-8), systemic and v

99 report that in mammalian cells PLC-generated IPs are rapidly recycled to inositol, and uncover the en

100 mponents of the habenulo-interpeduncular (Hb-IP) circuit is unknown.

101 Reducing the activity of Hb-IP nAChRs, either volitionally during smoking cessation

102 itization of cholinergic circuitry in the Hb-IP system.

103 In this study, cNIC-mediated changes to Hb-IP nAChR function were examined in mouse (male and femal

104 inositols, mostly inositol hexakisphosphate (IP(6)), detected in HEK293 cells, fibroblasts, iPSCs and

105 n be activated by inositol-hexakisphosphate (IP(6)).

106 In mutant cells, higher IP(6) level is expected to be associated with an increas

107 ry, our structural characterization of human IP(3)R-3 provides critical insights into the mechanistic

108 )) subunits and a point substitution, I559P (IP), to further stabilize the gp41(ECTO) components.

109 The SWE values at the IA, IP, and EA regions between the postmenopausal and premen

110 PCR and its relationship to immunophenotype (IP) and outcomes.

111 ckground signals from a immunoprecipitation (IP) 'target' dataset.

112 Using AGO2 immunoprecipitation (IP) followed by small-RNA sequencing, we find that miRNA

113 Through chromatin immunoprecipitation (IP) and gel shift assays, we found that RORalpha in the

114 ), titanium brush (TiB), and implantoplasty (IP).

115 mplant surface modification (implantoplasty [IP]).

116 lants showed lower net arsenic enrichment in IP for plants exposed to monomethylthioarsenate (MMMTA)

117 Mutations in IP(3)Rs have been increasingly associated with many debi

118 he participation of ID-trained physicians in IP programs.

119 ant of subtype-specific calcium signaling in IP(3)Rs.

120 B in human aortic SMCs resulted in increased IP-dependent cAMP production and consecutive facilitatio

121 phosphate starvation surprisingly increased IP(6) levels in a ITPK1-dependent manner, establishing a

122 microRNA-26a silencing reproduced AF-induced IP(3)R1 upregulation and nuclear diastolic Ca(2+)-loadin

123 P(3)-binding site and competitively inhibits IP(3) binding.

124 2 extracellular domain with IP(3)R1 inhibits IP(3)R1-mediated changes in cellular morphology.

125 ection nor the spleen after intraperitoneal (IP) infection required M2, although the reactivation def

126 ux1 strain was used with an intraperitoneal (IP) murine model of shigellosis to test the efficacy of

127 in, respectively, following intraperitoneal (IP) doses of 30 mg/kg.

128 JZL184 [4, 8 and 16 mg/kg, intraperitoneal (IP)] 4 h before testing caused dose-dependent inhibition

129 repeated scruff restraint, intraperitoneal (IP) injections and anaesthesia negated the reduction in

130 eriod IP, overall initiation rate constant k(IP), initiation oxidizability O(i), and the critical rev

131 the levels of proinflammatory cytokines KC, IP-10, and IL-33 in bronchoalveolar lavage (BAL) fluid.

132 d interferon gamma inducible protein 10 kDa (IP-10) (53-fold) and an increase in interleukin-1 recept

133 IP) immediately before kynurenine (33 mg/kg IP) and brain kynurenine and depression-like behavior we

134 Cfz was administered at 8 mg/kg (IP) and Met at 140 mg/kg (per os).

135 of obese ZSF1 rats with ABT-702 (1.5 mg/kg, IP for 8 weeks) prevented LV diastolic dysfunction, and

136 In VTA, 3alpha,5alpha-THP (15 mg/kg, IP) administration reduced TRAF6 (~20%), CRF (~30%), and

137 he CB(2) agonist JWH133 (0.3, 1 and 3 mg/kg, IP) also produced anxiolytic-like effects in TMT-stresse

138 eceived either vehicle or SBI-425 (25 mg/kg, IP) daily for 7 days.

139 ice were injected with L-leucine (300 mg/kg, IP) immediately before kynurenine (33 mg/kg IP) and brai

140 of the CB(2) inverse agonist AM630 (5 mg/kg, IP), but not the CB(1) inverse agonist rimonabant (1 mg/

141 e CB(1) inverse agonist rimonabant (1 mg/kg, IP).

142 nother MGL inhibitor, KML29 (4 and 16 mg/kg, IP).

143 8 weeks, then challenged with LPS (5 mg/kg; IP).

144 1b, the label 'IP-PBP3' above the second of the three blots incorrectly

145 ons than in macaques primed with DNA lacking IP-10 and boosted with MPLA-plus-alum-adjuvanted Env pro

146 grade or anterograde tracers into LDTg, LHb, IP, and MnR.

147 or ATP synthase inhibition, eliminated local IP(3)-mediated Ca(2+) release events.

148 nome BRD4 and gammaH2AX ChIP-Seq with R-loop IP qPCR reveals that BRD4 inhibition leads to accumulati

149 erity of liver cirrhosis (CTP score), mainly IP-10 and IL-6, which discriminated patients with Child-

150 Donors had a lower median IP than qualified lr-MSM and qualified hr-MSM (2 [interq

151 ardless of the implant surface modification (IP) being performed or not, the survival rate of implant

152 Ca(2+) mobilization, inositol monophosphate (IP(1)) accumulation, extracellular signal-regulated kina

153 ention period [IP]) or sequence 1-0 (6-month IP/3-month washout period/6-month CP).

154 SOS] with an isoleucine-to-proline mutation [IP] in gp41) alone, as well as B41 and BG505 coimmunizat

155 te that in hippocampal CA1 pyramidal neurons IP(3)- and Ry-receptors are associated with two function

156 garding treatment approach: IP (test) and no IP (control).

157 ial cardiomyocytes from AF patients, nuclear IP(3)R1-expression was significantly increased, with dec

158 +) puffs generated by stationary clusters of IP(3) receptors (IP(3)Rs).

159 Deregulation of IP(3)Rs leads to pathological calcium signaling and is i

160 A prior tracer dose of IP 74 MBq(124)I-omburtamab was used for radioimmuno-posi

161 ange of IP(3)R properties, but the effect of IP(3)R activation on Ca(2+) transient amplitude is depen

162 Flies with neuronal expression of IP(3)R(DN) exhibit flight deficits.

163 Expression of IP(3)R(DN) helped identify key flight-modulating dopamin

164 AF upregulated nuclear protein expression of IP(3)R1 (IP(3)R-type 1) and of phosphorylated CaMKII (im

165 In line with this facilitation of IP-mediated relaxation, iSM-Gprc5b-KO mice were protecte

166 al insights into the mechanistic function of IP(3)Rs and into subtype-specific regulation of these im

167 Here, we compared the impact of IP(6) on oligomerization and conformational equilibrium

168 These data suggest the involvement of IP(6)-mediated chelation on Pontocerebellar Hypoplasia d

169 Given current knowledge of IP(3)Rs, we develop a model describing the effect of fun

170 by distinct mechanisms at various levels of IP(3) stimulation.

171 Levels of IP-10, HGF, IL-6, MCP-1, MIP-1alpha, IL-12p70, IL-18, VE

172 Kenyan neonates had higher levels of IP-10, TNF-alpha, CRP, sCD14, and BAFF than United State

173 PRC5B increased the membrane localization of IP both in vitro and in vivo and that GPRC5B, but not ot

174 However, the precise mechanism of IP(3) binding and correlated domain dynamics in the NT t

175 These two modes of IP(3)-mediated Ca(2+) liberation have important implicat

176 uld be initiated by the transient opening of IP(3) receptors facing either the cytosol or the ud, and

177 l insight into the molecular pathogenesis of IP-DLBCL and indicates that anti-CD37 therapies will be

178 Here, we have compared the permeability of IP(3) and Ca(2+) through channels made from two connexin

179 In the presence of IP(6), arrestin-2 forms "infinite" chains, where each pr

180 nd higher-order oligomers in the presence of IP(6); we showed previously that trimeric state induces

181 the Ca(2+) transient shape to properties of IP(3)R activation.

182 (2+) transient duration for a broad range of IP(3)R properties, but the effect of IP(3)R activation o

183 d from sphingolipids, to enable synthesis of IP(6) We also found using PAGE mass assay that metabolic

184 a third set of traits, including a triad of IP-10, interleukin-10 and interleukin-6, anticipate subs

185 The AUC-ROC values of IP-10, IL-6, and both biomarkers combined (IP-10+IL-6) w

186 A high expression of IPs renders monocytes susceptible to IP inhibition, lead

187 alternative "soluble" route to synthesis of IPs.

188 n Ca(2+) transient amplitude is dependent on IP(3) concentration.

189 ense mutations to determine their effects on IP(3)R channel activity.

190 nding, complementing existing suggestions on IP(3)R activation mechanism.

191 il an SLC20A2-XPR1 interplay that depends on IPs such as PP-IPs and controls cellular phosphate homeo

192 ever, that NL trimers lacking the SOS and/or IP change can be affinity purified in amounts sufficient

193 bition (by autocamtide-2-related peptide) or IP(3)R-knockdown prevented the CaMKII-hyperphosphorylati

194 whether diabetogenic stressors alter RyR or IP(3)R function.

195 dMCS have lower survival compared with other IP-1 patients.

196 ethite was the dominant mineral phase in our IP.

197 th reporter account (RA) and involved party (IP) responses to determine if disruptive behavior was in

198 In endotoxin-stimulated human PBMCs, IP inhibition reduces the secretion of several proinflam

199 s of these forests in the Iberian Peninsula (IP) during the Late Quaternary, a period of profound cli

200 phase was characterized by induction period IP, overall initiation rate constant k(IP), initiation o

201 washout period/6-month intervention period [IP]) or sequence 1-0 (6-month IP/3-month washout period/

202 Higher induction periods (IPs) were recorded for encapsulated and antioxidant fort

203 Downstream inositol 3-phosphate (IP(3)) signaling appeared to be unaffected, as calcium s

204 stachyose, verbascose), inositol phosphates (IPs), trypsin inhibitors and lectins content.

205 Induced polarization (IP) mapping has gained increasing attention in the past

206 tified XPR1 as a key inositol polyphosphate (IP)-dependent regulator of this process.

207 l os in the anterior (IA, EA) and posterior (IP, EP) portions of the cervix using a transvaginal appr

208 ulation power (RP) and incapacitating power (IP).

209 kinase and pyrophosphatase switch whose 1-PP-IP products play an important role in a cellular adaptat

210 it reduced synthesis of the IP(5)-derived PP-IP(4) Nucleotide analysis showed that the knockout cells

211 PR1 but not with XPR1 harboring a mutated PP-IP-binding pocket.

212 llmark of altered inositol pyrophosphate (PP-IP) synthesis, and basal ATP levels were restored after

213 ovide atomic-resolution structures of the PP-IP products and unequivocally define that the Vip1 gene

214 pable of synthesis and destruction of D-1 PP-IPs.

215 PR1 interplay that depends on IPs such as PP-IPs and controls cellular phosphate homeostasis via the

216 Inositol diphosphates (PP-IPs), also known as inositol pyrophosphates, are high-en

217 physiologic hair follicle immune privilege (IP); the extent to which these functions are defective i

218 e CD8(+) CAR-T cells from infusion products (IPs) and blood of patients undergoing CD19 CAR-T immunot

219 the production of intermediate progenitors (IPs) and neurons is reduced, and neuron migration is imp

220 Intermediate progenitors (IPs, Tbr2+) pioneered migrations, supporting and guiding

221 r PGE(2) (EP(2) and EP(4)) and prostacyclin (IP) also enhanced the mannitol-induced bronchoconstricti

222 n (MCP)-1, interferon gamma-induced protein (IP)-10, monokine induced by IFN-gamma (MIG), epidermal g

223 (IL)-6, interferon-gamma inducible protein (IP)-10, soluble CD14 (sCD14), soluble CD163 (sCD163), ky

224 Using immunoaffinity purification (IP)-mass spectrometry (MS), we obtained additional suppo

225 ucible dominant negative form of the IP(3)R (IP(3)R(DN)).

226 uctural findings of the human type-3 IP(3)R (IP(3)R-3) obtained by cryo-EM (at an overall resolution

227 were observed after all treatments, with S/R-IP presenting the smoother and a less hydrophilic surfac

228 lated nuclear protein expression of IP(3)R1 (IP(3)R-type 1) and of phosphorylated CaMKII (immunohisto

229 phage markers, including chemokines (RANTES, IP-10), as well as chemotaxis in response to LPS and C5a

230 membranes obtained from cells expressing rat IP(3)R were unresponsive to polyP or its hydrolysis prod

231 second of the three blots incorrectly read 'IP-PBP1B'.

232 a, and Ewing sarcoma, respectively) received IP (131)I-omburtamab administered on an outpatient basis

233 hed that ANO1, TRPV1, and the IP(3) receptor IP(3)R1 were often found in close proximity to each othe

234 ignificantly enhanced prostacyclin receptor (IP)-dependent relaxation, whereas responses to other rel

235 yR) or inositol 1,4,5-triphosphate receptor (IP(3)R) dysfunction in the pathophysiology of diabetes r

236 ype 1 inositol 1,4,5-trisphosphate receptor (IP(3)R1) as a specific synaptic interaction partner of t

237 d by stationary clusters of IP(3) receptors (IP(3)Rs).

238 sitol 1,4,5-trisphosphate (IP(3)) receptors (IP(3)Rs), which form tetrameric channels, play pivotal r

239 rough inositol 1,4,5-triphosphate receptors (IP(3)Rs) is essential for the regulation of numerous phy

240 via inositol 1,4,5-trisphosphate receptors (IP(3)Rs), engaging hypertrophic signaling pathways.

241 ough inositol 1,4,5-trisphosphate receptors (IP(3)Rs).

242 and differentiation by negatively regulating IP signaling.

243 omarkers linked to an inflammatory response (IP-10, IL-8, IL-6, and OPG), endothelial dysfunction (sV

244 ients received (131)I-omburtamab as a single IP injection at escalated activities from 1.11 to 3.33/G

245 hat are shown to have a distinctive spectral IP response.

246 (2+) signaling proteins: Orai1, PMCA, STIM1, IP(3) receptors, and SERCA2 at the ER/PM junctions to me

247 )), and neutral or alkaline pH can stimulate IP(3)-generated currents.

248 a G(alpha16)/G(alphaz) chimera, to stimulate IP(1) accumulation.

249 Results from the tandem IP indicated that another component of the JUND-containi

250 Furthermore we demonstrate that IP(3)-mediated Ca(2+) release in the cytosol increases t

251 We found that IP inhibition with the irreversible LMP7/LMP2 inhibitor

252 A key result of our study is that IP(3)R activation increases Ca(2+) transient duration fo

253 Here we report that IP-RP is less suitable compared to the conventional ion-

254 We show that IP(3)-mediated Ca(2+) release depends on Ca(2+) but not

255 assays established that ANO1, TRPV1, and the IP(3) receptor IP(3)R1 were often found in close proximi

256 a locally convey calcium signals between the IP(3) receptors (IP3R) and the mitochondrial calcium uni

257 In bronchi precontracted by carbachol, the IP receptor agonist cicaprost induced profound relaxatio

258 eems to play a major role in determining the IP(3) binding affinity of IBC in the presence/absence of

259 pends on the location of the mutation in the IP(3)R structure, as well as on the stoichiometry of mut

260 t likely accounts for the differences in the IP(6) effect.

261 located in the primary sequence occupies the IP(3)-binding site and competitively inhibits IP(3) bind

262 congruent with paleoclimatic records of the IP and showed that range shifts of these contact zones c

263 d an inducible dominant negative form of the IP(3)R (IP(3)R(DN)).

264 8) and also exhibit reduced synthesis of the IP(5)-derived PP-IP(4) Nucleotide analysis showed that t

265 ckout cells have nondetectable levels of the IP(6)-derived IP(7) and IP(8) and also exhibit reduced s

266 Targeting the IP in autoimmune diseases proved to be therapeutically e

267 0914-induced cell death, indicating that the IP is required to maintain protein turnover in monocytes

268 n dynamics in the NT that are central to the IP(3)R activation, remains unknown.

269 While the IP(3)-sensitive Ca(2+) store refilling requires Orai2 ch

270 l diversity of CAR-T cells is highest in the IPs and declines following infusion.

271 defective in patients with AA; and how this IP-protective role could be restored therapeutically in

272 e transmitter phenotype of LDTg afferents to IP by combining retrograde tracing with immunofluorescen

273 nown to occur relatively quickly compared to IP, the cochlear amplification observed in LCM could att

274 onversely, Cx50 channels were impermeable to IP(3), while exhibiting high permeation of Ca(2+).

275 Reduced Cx50 permeability to IP(3) could play a role in regulating cell division and

276 Cx43 channels were permeable to IP(3) and Ca(2+).

277 ization, generally with a similar potency to IP(1) accumulation and ERK1/2 phosphorylation, whereas C

278 Thus, in response to IP(6), the two non-visual arrestins oligomerize in diffe

279 K1-dependent manner, establishing a route to IP(6) controlled by cellular metabolic status, that is n

280 sion of IPs renders monocytes susceptible to IP inhibition, leading to an accumulation of polyubiquit

281 okine biomarkers (IL-6, IL-8, IL-10, TRAIL & IP-10), that is attributed as a sign of the body's host

282 onsisting of PLCbeta, inositol triphosphate (IP(3)), IP(3) receptors, and Ryanodine receptors is requ

283 e propose that inositol 1,4,5-trisphosphate (IP(3) )-dependent Ca(2+) signalling gives rise to an exc

284 sion decreases inositol 1,4,5-trisphosphate (IP(3)) levels and ameliorates Purkinje cell degeneration

285 The inositol 1,4,5-trisphosphate (IP(3)) receptors (IP(3)Rs), which form tetrameric channe

286 Upon inositol trisphosphate (IP(3)) stimulation of non-excitable cells, including vas

287 ding-block' model of inositol trisphosphate (IP(3))-mediated Ca(2+) liberation posits that cell-wide

288 in which the genes for all three vertebrate IP(3)Rs were stably ablated (DT40-3KO).

289 beta results in sustained Ca(2+) release via IP(3) and ryanodine receptors to activate calcineurin.

290 g-range control of endothelial signaling via IP(3)-evoked local Ca(2+) release in intact endothelium.

291 nce of Child-Pugh B cirrhosis (CTP 7-9) were IP-10 (p-value= 0.008) and IL-6 (p-value=0.002).

292 urgical, medical, and other specialties were IPs 43%, 35%, and 22%, respectively; 73% had only one ev

293 Cellular mechanism(s) by which IP(3)Rs modulate neuronal function for specific behaviou

294 Taken together, our data reveal why IP inhibition is particularly effective in the suppressi

295 With IP injection, the DPOAEs recovered fully, whereas the EP

296 elate complex conductivities associated with IP to intrinsic physical properties of the corresponding

297 tion of the Caspr2 extracellular domain with IP(3)R1 inhibits IP(3)R1-mediated changes in cellular mo

298 rrelated 'clam closure' dynamics of IBC with IP(3)-binding, complementing existing suggestions on IP(

299 coupled receptors, physically interacts with IP.

300 IPs synthesis is believed to originate with IP(3) generated from PIP(2) by phospholipase C (PLC).